Adherence

Five things for pharma marketers to know: Tuesday, June 9

Five things for pharma marketers to know: Tuesday, June 9

By

Study shows Merck's Januvia does not increase heart risks; a former Genentech exec launches a behavioral health business; lawmakers want black-box warnings on more opioids

WebMD to launch app for Apple's smartwatch

WebMD to launch app for Apple's smartwatch

By

The small screen makes it a user-friendly medication adherence tool.

The Delicate Human Side of Marketing Science

The Delicate Human Side of Marketing Science

For all the scientific tools that have fallen into our hands in the past few years, we are still largely falling short in our efforts to influence our audiences' behaviors.

The New Holistic Approach to Leveraging a Multi-Channel Contact Center

The New Holistic Approach to Leveraging a Multi-Channel Contact Center

Delivering smarter dynamic communications rather than static timed communications based on self-reported data can help connect patients to information and support that drive brand loyalty and program success.

Survey shows docs overestimate adherence

Survey shows docs overestimate adherence

By

A small physician survey shows doctors think their patients have higher adherence rates than the norm.

Five things for pharma marketers to know: Friday, January 30

Five things for pharma marketers to know: Friday, January 30

By

Obama's precision medicine initiative looks set for bipartisan support, Valeant has offered $296 million to buy Dendreon and researchers say Roche's Tamiflu works.

Talking, braille labels to show up in mailboxes

A CVS Health/American Council of the Blind collaboration means some visually impaired patients will soon have more engaging prescription labels.

High deductibles, costs keep patients away

High deductibles, costs keep patients away

By

More cost data for the file the latest data shows that up-front healthcare costs are prompting many patients to delay office visits.

Researchers: Pharmacy deserts contribute to access issues

Researchers: Pharmacy deserts contribute to access issues

By

Researchers studying the distribution of brick-and-mortar pharmacies in Chicago link adherence issues with geographic barriers to care.

Rate of Sovaldi non-adherence points to need for patient support

Rate of Sovaldi non-adherence points to need for patient support

By

A mélange of new treatments awaiting approval and a lack of patient support are driving down drug utilization for Gilead's HCV blockbuster, according to a new study.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.

Visual continuity key to patient adherence

Visual continuity key to patient adherence

By

Researchers at the Brigham and Women's Hospital found that continuity in color and shape have a significant impact on whether patients stick with a prescription regimen.

Key to successful digital outreach: think small

Key to successful digital outreach: think small

By

Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.

Study links patient confidence to Rx adherence

Study links patient confidence to Rx adherence

By

Researchers found a correlation between patients feeling involved and how well they stick—if they stick—to their medication regimens.

Study shows sample-drug adherence link

Study shows sample-drug adherence link

By

A survey of patients found greater prescription drug adherence among patients who received a free 30-day sample in addition to a prescription.

Study links adherence with side effect worries

A study showed that side-effect fears keep asthmatics from sticking to medication regimens.

Pitting Big Data against nonadherence

Pitting Big Data against nonadherence

By

A young company is hoping its analytics platform can help doctors and pharma figure out who's going to stop taking their medication, and get them back on track.

Another study about doctor-patient divide

Novo's global diabetes study finds that only 29% of polled patients were asked what they thought about prescribed regimens.

E-prescribing systems not so pharma friendly

E-prescribing systems not so pharma friendly

By

A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.

Retail pharmacies up consumer satisfaction

Retail pharmacies up consumer satisfaction

By

A study shows consumers are increasingly pleased with retail pharmacies, compared to mail order pharmacies, which are often considered a key means of driving adherence and lowering healthcare coverage costs.

Healthcare reform roundup

Healthcare reform roundup

By

A roundup of some exchange-related news circling the web.

Researchers propose new Rx adherence model

Researchers propose new Rx adherence model

By

Researchers say using additional data points offers greater insight into patient-adherence patterns.

Business briefs: Gilead, AstraZeneca, Amgen, Otsuka

Gilead in an other sofosbuvir IP fight; study says patients not sticking with Amgen's Brilinta; AstraZeneca and Cytokinetics drug fails to hit Phase II target; Otsuka gets a CRL

Business briefs: Eisai, AHRQ, mWellnesss

Eisai uses a lawsuit to prompt the DEA, AHRQ gets a new director, mWellness runs into adherence issues.

"Sensor you swallow" passes psych test

"Sensor you swallow" passes psych test

By

Proteus Digital Health's ingestible sensor shows utility as an adherence tool for those on psych meds, a study suggests.

Studies provide more clues to patient adherence, medical needs

By

Three studies take on different angles of the patient experience. Spoiler alert: no cost increases are mentioned.

Researchers spot $213B of wasteful drug spending

Researchers spot $213B of wasteful drug spending

By

For a country bent on healthcare cost control, findings represent an opportunity: authors say nearly 8% of the nation's total outlay could have been avoided.

Weight-loss category expands by one

By

Eisai brings Belivq to 20,000 US pharmacies, along with 200 sales reps and a physician marketing push.

Business briefs: Angelina Jolie, adherence, Sanofi, Teva, AbbVie

Jolie takes on cancer awareness role, researchers identify another adherence gap, Sanofi gets slapped for scare tactics, Teva may compete for Adcock, AbbVie R&D chief leaves

Studies show cheaper drugs don't add up to greater use

By

Two studies released show that the story behind lower consumer healthspend isn't about generics improving health.


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.